Sacha J Howell

25PUBLICATIONS

152CO-AUTHORS

Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHealth and ecological risk assessmentPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jul 09, 2026

Reply to: The Role of Risk-Reducing Bilateral Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.

|May 25, 2026

Risk-reducing surgery, risk-reducing medication, and surveillance in young BRCA carriers with breast cancer: considering all the options.

|May 19, 2026

Exploratory analysis of PTEN deficiency by immunohistochemistry from the Phase III CAPItello-291 trial.

|Feb 04, 2026

Survival Outcomes With or Without Risk-Reducing Mastectomy in BRCA1 and BRCA2 Pathogenic Variant Carriers.

Ashu Gandhi, Sacha J Howell, Elaine F Harkness

|Jan 06, 2026

The breast cancer risk assessment pathway in England: a systems analysis of current challenges and ways to improve.

Maria Valasaki, Lily C Taylor, Victoria G Woof

|Nov 05, 2025

Anti-progestin therapy targets hallmarks of breast cancer risk.

Bruno M Simões, Robert Pedley, Curtis W McCloskey

Pageof 5

Frequent Collaborators

D Gareth Evans

Elaine Harkness

David P French

Michelle Harvie

Anthony Howell

Robert B Clarke

Bruno M Simões

Mary Pegington

Susan M Astley

Julia Mueller

Frequent Collaborators

D Gareth Evans

Elaine Harkness

David P French

Michelle Harvie